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Abstract 31 
This study tested the hypothesis that sweat rate during passive heat stress is limited by 32 
baroreceptor unloading associated with heat stress. Two protocols were performed in which 33 
healthy subjects underwent passive heat stress that elicited an increase in intestinal 34 
temperature of ~1.8°C.  Upon attaining this level of hyperthermia, in protocol one (n=10, 3 35 
females) a bolus (19 ml/kg) of warm (~38°C) isotonic saline was rapidly (5-10 min) infused 36 
intravenously to elevate central venous pressure (CVP), while in protocol two (n=11, 5 37 
females) phenylephrine was infused intravenously (60-120 μg/min) to return mean arterial 38 
pressure (MAP) to normothermic levels. Protocol one: Heat stress reduced CVP from 3.9 ± 1.9 39 
mmHg (normothermia) to -0.6 ± 1.4 mmHg (P<0.001), while saline infusion returned CVP to 40 
normothermic levels (5.1 ± 1.7 mmHg; P>0.999). Sweat rate was elevated by heat stress (1.21 41 
± 0.44 mg/cm2/min) but remained unchanged during rapid saline infusion (1.26 ± 0.47 42 
mg/cm2/min, P=0.5), whereas CVC increased from 77 ± 10 to 101 ± 20% of local heating max 43 
(P=0.029). Protocol two: MAP was reduced with heat stress from 85 ± 7 mmHg to 76 ± 8 44 
mmHg (P=0.048). Although phenylephrine infusion returned MAP to normothermic levels (88 ± 45 
7 mmHg; P>0.999), sweat rate remained unchanged during phenylephrine infusion (1.39 ± 46 
0.22 mg/cm2/min vs. 1.41 ± 0.24 mg/cm2/min; P>0.999). These data indicate that both 47 
cardiopulmonary and arterial baroreceptor unloading do not limit increases in sweat rate during 48 
passive heat stress.  49 
 50 
Keywords: Arterial baroreceptors; Cardiopulmonary baroreceptors; Hyperthermia; Central 51 
venous pressure; Skin blood flow; Sweat rate. 52 
  53 
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INTRODUCTION 54 
 Sweating and cutaneous vasodilation are elicited not only by increases in core and skin 55 
temperatures, but also by non-thermal factors. For instance, central command, 56 
metaboreceptors, mechanoreceptors, and osmoreceptors all independently affect both 57 
sweating and cutaneous vasodilation (20, 23). In contrast, baroreceptors have long been 58 
known to influence cutaneous vasodilation (11), but their influence upon sweat rate remains 59 
debatable (31).  60 
Passive heat stress reduces cardiac filling pressures (38) and arterial blood pressure 61 
(7), unloading both cardiopulmonary and arterial baroreceptors respectively. The vast majority 62 
of studies examining a potential role for baroreceptors in the control of sweating during passive 63 
heat stress have done so using perturbations that further unload baroreceptors. Such studies, 64 
using passive heat stress in combination with either head-up tilt (37), pharmacological agents 65 
(36), or during lower body negative pressure (1, 24), have consistently shown that further 66 
baroreceptor unloading does not affect sweat rate or its thermal sensitivity. In contrast, 67 
baroreceptor unloading modulates sweat rate during the recovery from dynamic exercise (19), 68 
which is also characterized by a state of arterial and cardiopulmonary baroreceptor unloading, 69 
as cardiac filling and arterial blood pressures are reduced (9, 10). Rather than eliciting further 70 
baroreceptor unloading, however, post-exercise studies have shown that arterial and/or 71 
cardiopulmonary baroreceptor “reloading” maintains sweat rate at elevated levels, particularly 72 
during the early stages of recovery following dynamic exercise (13-15, 17, 28). It is therefore 73 
conceivable that the discrepancy between passive heat stress and post-exercise studies 74 
regarding the potential role of baroreceptors in modulating sweat rate results from the former 75 
relying on procedures that cause further baroreceptor unloading (e.g., lower body negative 76 
pressure, head-up tilt, pharmacological reductions in blood pressure), whereas the latter relied 77 
upon maneuvers that cause baroreceptor reloading (e.g. lower body positive pressure, head-78 
down tilt, supine posture).  79 
Few studies have attempted to examine whether baroreceptor reloading can influence 80 
sweat rate during passive heat stress. Our laboratory has previously shown that brief 81 
sequential decreases and increases in mean arterial pressure do not cause parallel changes in 82 
sweat rate in passively heat stressed subjects (36). Furthermore, sweat rate is unaffected 83 
during passive heating performed in a head-down tilt position relative to the upright seated 84 
posture (18). However, findings from both studies are limited in that arterial baroreceptor 85 
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reloading was very brief (<1 min) and immediately followed sodium nitroprussside infusion and 86 
subsequent arterial baroreceptor unloading (36), while head-down tilt did not fully offset 87 
baroreceptor unloading associated with heat stress (18). As such, it remains to be determined 88 
whether baroreceptor unloading during heat stress limits the increase in sweat rate and if so, 89 
whether one baroreceptor population (arterial vs. cardiopulmonary) is primarily responsible. 90 
Our laboratory has previously shown that cardiopulmonary baroreceptor reloading via rapid 91 
saline infusion allows for greater increases in cutaneous vasodilation during passive heat 92 
stress (3). These findings suggest that cardiopulmonary baroreceptor unloading limits the 93 
increase in cutaneous vasodilation during passive heat stress in humans. Therefore, the 94 
purpose of this study was to examine whether baroreceptor unloading also limits the increase 95 
in sweat rate during passive heat stress. We also examined potential separate influences of 96 
cardiopulmonary and arterial baroreceptors by performing procedures that primarily targeted 97 
each population. We tested the hypothesis that both cardiopulmonary and arterial baroreceptor 98 
unloading limit the increase in sweat rate during passive heat stress, such that reloading both 99 
baroreceptor populations would further elevate sweat rate.   100 
 101 
 102 
METHODS 103 
Two protocols were undertaken. Ten subjects (3 females) participated in protocol one, 104 
while 11 subjects (5 females) participated in protocol two. Subject characteristics (mean ± SD) 105 
for protocol one were: age, 29 ± 5 y; height, 177 ± 10 cm; weight: 75.5 ± 12.2 kg and for 106 
protocol two were: age, 26 ± 5 y; height, 178 ± 12 cm; weight: 71.3 ± 14.9 kg. Subjects were 107 
non-smokers, not taking medications, and were free of any known cardiovascular, metabolic, 108 
neurological, or psychological diseases. Since only within subject comparisons were performed 109 
in the current study (see statistical analysis section), menstrual cycle phase was recorded but 110 
not controlled for in female subjects. Each subject was fully informed of the experimental 111 
procedures and possible risks before giving informed, written consent. Both protocols and the 112 
informed consent were approved by the Institutional Review Boards at the University of Texas 113 
Southwestern Medical Center at Dallas and Texas Health Presbyterian Hospital of Dallas, and 114 
all procedures conformed to the standards set by the Declaration of Helsinki. Subjects arrived 115 
at the laboratory euhydrated, confirmed via urine specific gravity (protocol one: 1.015 ± 0.008, 116 
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protocol two: 1.012 ± 0.008), and were asked to refrain from strenuous exercise, alcohol and 117 
caffeine for a period of 24h prior to their arrival.   118 
 119 
Instrumentation 120 
Both protocols: Approximately 120 min prior to experimental testing, each subject 121 
swallowed a telemetry pill (HQ Inc., Palmetto, FL, USA) for the measurement of intestinal 122 
temperature. Mean skin temperature was measured as the weighted average of six 123 
thermocouples (abdomen, calf, chest, lower back, thigh, upper back) attached to the skin (34). 124 
Mean body temperature was subsequently calculated as: intestinal temperature × 0.8 + mean 125 
skin temperature × 0.2. Body temperature was controlled via a water-perfused tube lined suit 126 
(Med-Eng, Ottawa, ON, Canada) that covered the entire body except the head, hands, one 127 
forearm, and the feet. Blankets were placed on the subjects to minimize any potential heat loss 128 
from sweat evaporation. Heart rate was continuously recorded from an electrocardiogram (HP 129 
Patient Monitor, Agilent, Santa Clara, CA, USA) interfaced with a cardiotachometer (CWE, 130 
Ardmore, PA, USA).  Beat-to-beat blood pressure was measured continuously via the Penaz 131 
method (Finometer Pro, FMS, Amsterdam, The Netherlands), which was confirmed 132 
intermittently via auscultation of the brachial artery by electrosphygmomanometry (Tango+, 133 
SunTech, Raleigh, NC, USA). Forearm (local) sweat rate was measured by placing a plastic 134 
capsule covering 2.83 cm2 of skin on the ventral surface of the exposed forearm.  This capsule 135 
was perfused with dry nitrogen at a flow rate of 0.3 L/min. Water vapor in the gas exiting the 136 
capsule was measured by capacitance hygrometry (Vaisala, Woburn, WA, USA), and forearm 137 
sweat rate was calculated by multiplying the humidity output (in g/m3) by flow rate and dividing 138 
that value by the surface area of the capsule.    139 
 140 
Instrumentation unique to protocol one: Skin blood flow was measured via laser-Doppler 141 
flowmetry (Periflux System 5000, Perimed, Stockholm, Sweden) from the ventral surface of the 142 
uncovered forearm. At the end of the experimental protocol, the area surrounding the laser-143 
Doppler probe was heated to 44°C for 30 minutes to produce a locally induced maximum skin 144 
blood flow (16).  Cutaneous vascular conductance was calculated as laser-Doppler flux divided 145 
by mean arterial pressure and expressed as a percentage of maximum. In 8 of 10 subjects, a 146 
peripherally inserted central venous catheter was advanced into the superior vena cava via the 147 
basilic vein. Positioning of the central venous catheter was confirmed by: 1) the distance that 148 
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the catheter was advanced, 2) observation of adequate pressure waveforms, and 3) an 149 
appropriate rapid rise and fall in pressure during a Valsalva and Mueller maneuver, 150 
respectively. The central venous catheter was connected to a pressure transducer and zeroed 151 
at the position of the midaxillary line. This catheter was used for continuous measurement of 152 
central venous pressure (CVP).  153 
 154 
Experimental protocol one 155 
This protocol was performed to determine whether reloading of primarily the 156 
cardiopulmonary baroreceptors, via restoring hyperthermia-induced reductions in CVP to 157 
normothermic levels, increased sweat rate during passive heat stress. Following 158 
instrumentation, subjects rested in the supine position for a minimum of 30 min, while 34°C 159 
water circulated through the suit, after which baseline normothermic thermal and hemodynamic 160 
data were obtained.  Subjects were then passively heated by circulating ~49°C water through 161 
the suit. After intestinal temperature increased ~1.8°C, warmed (~38°C) isotonic saline was 162 
rapidly administered over 6.9 ± 2.1 min through a catheter placed in an antecubital vein 163 
(different from the one used to place the CVP catheter) sufficient to return CVP to pre-heat 164 
stress levels (2, 3). After the infusion, mean skin temperature was returned to pre-heat stress 165 
levels by perfusing the suit with cool (~20°C) water during which time maximum skin blood flow 166 
was determined by local heating.   167 
 168 
Experimental protocol two 169 
This protocol was performed to determine whether reloading of primarily arterial 170 
baroreceptors, via restoring hyperthermia-induced reductions in mean arterial pressure (MAP) 171 
to normothermic levels, increased sweat rate during passive heat stress. Similar to protocol 172 
one, subjects rested in the supine position following instrumentation but their lower legs were 173 
suspended below heart level (legs were bent at knees at ~73° angle), promoting reductions in 174 
MAP during passive heat stress. Following a minimum of 30 min, during which time 34°C water 175 
circulated through the suit, baseline normothermic thermal and hemodynamic data were 176 
obtained.  Subjects were then passively heated by circulating ~49°C water through the suit. 177 
After intestinal temperature increased ~1.8°C, phenylephrine (60–120 μg/min) was 178 
intravenously titrated for 5 min to increase MAP 12 ± 3 mmHg, restoring MAP to normothermic 179 
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levels. Skin blood flow was not measured in this protocol as phenylephrine acts directly on the 180 
cutaneous vasculature, independent of neural control. 181 
 182 
Data and statistical analyses 183 
Data were acquired continuously at 50 Hz throughout the experiment (Biopac, Santa 184 
Barbara, CA, USA). Data are presented as a 1 min average immediately before whole-body 185 
heating (normothermia) and immediately before rapid saline (protocol one) or phenylephrine 186 
(protocol two) infusion (hyperthermia), while data throughout the saline and phenylephrine 187 
infusions are presented as minute averages. The duration of the saline infusion differed 188 
between subjects (range: 5 – 10 min).  Therefore, the first 4 min of these data, and data during 189 
the final minute of the infusion, are presented. All data were statistically analyzed using one-190 
way repeated-measures analysis of variance with the repeated factor of time (normothermia, 191 
hyperthermia, as well as min 1-4 and the final min, or min 1 through 5 of rapid saline and 192 
phenylephrine infusions, respectively), and where appropriate, post hoc Bonferroni pair-wise 193 
comparisons were made. Data were analyzed using GraphPad Prism (version 6, GraphPad 194 
Software, Inc., La Jolla, CA, USA) with a priori statistical significance set at P≤0.05.  All data 195 
are reported as mean ± SD.  196 
 197 
RESULTS 198 
 199 
Protocol one 200 
Passive heat stress increased intestinal temperature, mean skin temperature, and heart 201 
rate (all P<0.001), while MAP was unchanged (P=0.765, Table 1). CVP decreased (P<0.001) 202 
with heat stress, while forearm sweat rate and CVC were increased (P<0.001, Figure 1).  203 
Rapid infusion of 19 ± 2 ml/kg of saline raised CVP (P≤0.019), returning it to normothermic 204 
values (P>0.999, Figure 1). This saline infusion caused further increases in CVC (P≤0.051), 205 
but did not cause any further changes in forearm sweat rate (P≥0.439, Figure 1).  By the end of 206 
the saline infusion, intestinal temperature had further increased by 0.2 ± 0.1°C (P=0.005), 207 
while MAP decreased to values that were lower than during normothermia (P=0.029, Table 1). 208 
 209 
Protocol two 210 
Passive heat stress increased (P<0.001) intestinal temperature, mean skin temperature, 211 
heart rate, and forearm sweat rate (Table 2, Figure 2), while MAP decreased by 9 ± 7 mmHg 212 
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(P=0.048, Figure 2). Phenylephrine infusion increased MAP (P<0.001), restoring it to 213 
normothermic values (P>0.999), but did not affect forearm sweat rate (P>0.999, Figure 2).  By 214 
the end of the phenylephrine infusion, intestinal temperature had further increased by 0.2 ± 215 
0.1°C (P<0.001), while heart rate decreased (P<0.001) relative to that occurring during 216 
hyperthermia (Table 2). 217 
 218 
DISCUSSION 219 
This study tested the hypothesis that baroreceptor unloading associated with passive 220 
heat stress limits the increase in sweat rate. Contrary to our hypothesis, reloading of primarily 221 
cardiopulmonary (via rapid saline infusion) and primarily arterial (via phenylephrine infusion) 222 
baroreceptors did not elicit further increases in sweat rate (Figures 1 and 2). Therefore, the 223 
current results suggest that baroreceptor unloading coincident with severe passive heat stress 224 
does not limit increases in sweat rate during this exposure in humans.  225 
 226 
  A number of studies have examined a potential role for baroreceptors in modulating 227 
sweat rate during exercise, passive heat stress, and during the recovery from dynamic 228 
exercise. Findings from early studies comparing thermoregulatory responses during supine 229 
(i.e. baroreceptor loading) and upright (i.e. baroreceptor unloading) exercise suggest that 230 
baroreceptor unloading during exercise does not affect sweat production (8, 21), but that 231 
upright exercise delays the onset threshold for cutaneous vasodilation (12, 29). Subsequently, 232 
studies using lower body negative pressure established a potential role for cardiopulmonary 233 
baroreceptor unloading in altering the neural drive (i.e. skin sympathetic nerve activity) for 234 
sweating (5) as well as both the onset threshold for sweat production (27) and its sensitivity to 235 
changes in core temperature (26, 32). These latter findings, however, were largely attributed to 236 
potential reductions in skin temperature that accompany the use of lower body negative 237 
pressure (35), which can decrease sweat rate independent of baroreceptor unloading (39). 238 
Consequently, a number of studies using alternative methods to unload baroreceptors, while 239 
minimizing decreases in skin temperature, were undertaken. In these studies, passive heat 240 
stress in combination with either head-up tilt (37), pharmacological agents (36), or during lower 241 
body negative pressure with or without small decreases in skin temperature (1, 4, 24) have 242 
consistently shown that further baroreceptor unloading (relative to that which occurs during 243 
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heat stress itself) does not affect skin sympathetic nerve activity, sweat rate or its thermal 244 
sensitivity.  245 
 246 
In contrast to passive heat stress studies, baroreceptor modulation of sweating has 247 
consistently been demonstrated during the recovery from dynamic exercise. Rather than 248 
eliciting further baroreceptor unloading, as in the aforementioned passive heat stress studies, 249 
most of these studies reversed the cardiopulmonary and/or arterial baroreceptor unloading that 250 
typically occurs post-exercise (9, 10). For example, Journeay et al. (14) used lower body 251 
positive pressure to reload cardiopulmonary and arterial baroreceptors following dynamic 252 
exercise and observed elevated sweat rates that ultimately resulted in a faster return of core 253 
temperature to baseline compared to a control (i.e., no positive pressure) condition. Similarly, a 254 
number of other post-exercise studies have shown that baroreceptor reloading maintains 255 
sweat rate at elevated levels compared to when baroreceptors are naturally unloaded during 256 
inactive recovery following dynamic exercise (13, 15, 17, 28). In light of the findings from these 257 
studies, we hypothesized that the cardiopulmonary and arterial baroreceptor unloading which 258 
occurs during passive heat stress places a “brake” on sweat rate. If so, then releasing that 259 
figurative brake, by returning the loading status of these baroreceptors to pre-heat stress 260 
levels, would elicit further increases in sweat rate. Contrary to this hypothesis, however, sweat 261 
rate remained unchanged during both rapid saline (Figure 1) and phenylephrine (Figure 2) 262 
infusions. In contrast, and as previously shown (3), cardiopulmonary baroreceptor reloading via 263 
rapid saline infusion elicited large increases in cutaneous vascular conductance (upwards of 264 
25%; Figure 1). It should be considered that small decreases in MAP (i.e., arterial baroreceptor 265 
unloading) during rapid saline infusion may have negated potential increases in sweat rate 266 
during reloading of cardiopulmonary baroreceptors. However, a targeted reloading of arterial 267 
baroreceptors via phenylephrine infusion had no effect on sweat rate during protocol two 268 
(Figure 2), suggesting that the lack of increase in sweat rate during rapid saline infusion is not 269 
confounded by small decreases in MAP. Overall, the current data suggest that while 270 
cardiopulmonary baroreceptor unloading may limit increases in cutaneous vasodilation during 271 
passive heating in humans, they do not appear to limit the increase in sweat rate. Furthermore, 272 
these observations support prior observations of differential baroreceptor control of skin blood 273 
flow and sweating in the passively heat stressed human (12).   274 
    275 
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It should be noted that at least two previous studies have examined the effect of 276 
baroreceptor loading on sweat rate during passive heat stress, although definite conclusions 277 
as to a potential modulation of sweat rate by baroreceptors could not be reached. Our 278 
laboratory previously reported that sweat rate during passive heat stress was unaffected by 279 
bolus infusions of sodium nitroprusside immediately followed by phenylephrine that elicited 280 
sequential decreases and increases in blood pressure (36). Although these findings suggested 281 
that arterial baroreceptor loading does not affect sweat rate during passive heat stress, no 282 
insight into a potential role for cardiopulmonary baroreceptor loading could be assessed. 283 
Moreover, conclusions regarding arterial baroreceptor control of sweating from that study are 284 
clouded by the fact that: 1) in all cases, blood pressure was first reduced by sodium 285 
nitroprusside, which likely affected the extent of arterial baroreceptor reloading during 286 
subsequent phenylephrine administration, and 2) the short period of time blood pressure was 287 
elevated (typically <1 min) as a result of the bolus approach, which may have been insufficient 288 
to observe any effects upon sweat rate. Furthermore, Kenny et al. (18) compared sweating and 289 
cutaneous vascular conductance during passive heat stress in the upright seated position 290 
(baroreceptor unloading) and during 15° head-down tilt (baroreceptor loading). Although they 291 
did not observe any differences in either sweating or cutaneous vascular conductance 292 
between conditions, it is possible that 15° head-down tilt was not sufficient to fully reload 293 
baroreceptors, as it did not return blood pressure to normothermic levels during the passive 294 
heat stress period. Furthermore, 15° head-down tilt did not increase cutaneous vascular 295 
conductance, despite cardiopulmonary baroreceptor reloading being clearly capable of eliciting 296 
further increases in cutaneous vascular conductance [(3), and Figure 1]. Overall, however, the 297 
findings of the current study support these previous observations, and extend them by 298 
providing conclusive evidence that reloading of either cardiopulmonary or arterial 299 
baroreceptors does not affect sweat rate during passive heat stress in humans.  300 
 301 
Considerations. The findings of the current study are partly dependent upon the 302 
assumption that sweat rate could be further elevated during rapid saline and phenylephrine 303 
infusion periods. Considering that core temperature increased ~1.8°C during passive heating, 304 
it is possible that any influence of baroreceptor unloading may have been overridden by the 305 
high thermal drive. Indeed, previous studies have shown that the relative influence of non-306 
thermal factors, including baroreceptors, is attenuated when thermal drive is elevated (6, 22). 307 
Furthermore, maximal levels of forearm sweat rate may have been attained during the heating 308 
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period. Both possibilities would have created a “ceiling effect” thus limiting any further 309 
increases in sweat rate during baroreceptor reloading. While these considerations may have 310 
limited the potential to observe further increases in forearm sweat rate during the baroreceptor 311 
reloading periods, their possible occurrence would nonetheless suggest that baroreceptor 312 
unloading did not limit the increase in sweat rate during severe passive heating in the current 313 
study. If baroreceptor unloading associated with heat stress modulates sweat rate, we would 314 
have expected the thermal drive to be insufficient to override this baroreflex influence, which 315 
would have effectively limited the increase in sweat rate. This scenario would have provided a 316 
background against which to observe further increases in forearm sweat rate during 317 
baroreceptor reloading. Therefore, the lack of increase in forearm sweat rate during both rapid 318 
saline and phenylephrine infusions indicates that baroreceptor unloading during severe 319 
passive heating did not impede increases in forearm sweat rate. That said, although forearm 320 
sweat rate is representative of other non-glabrous areas during passive heating (33) and it 321 
responds to non-thermal stimuli similarly to other non-glabrous skin sites (25), we cannot rule 322 
out the possibility that sweat rate in other areas of the body increased during the baroreceptor 323 
reloading interventions. 324 
 325 
Perspectives. The findings from the current study add to a growing body of recent 326 
literature indicating that baroreceptors do not influence sweat production during passive heat 327 
stress (1, 4, 24, 36, 37). A consistent lack of baroreceptor modulation of sweat production 328 
during passive heat stress is puzzling compared to baroreceptor modulation of sweating during 329 
(26, 27) and following (13-15, 17, 28) dynamic exercise. Although speculative, it is possible 330 
that factors specific to dynamic exercise engage baroreceptors in the control of sweating. 331 
Future studies should consider examining this possibility. Determining whether baroreceptors 332 
modulate sweat rate during passive heat stress is important as, from a practical perspective, 333 
prolonged sweating in hot environments often leads to dehydration (30), exacerbating 334 
baroreceptor unloading. Thus, it is perhaps unsurprising that a number of studies have 335 
examined a potential role for baroreceptor unloading in eliciting volume preservation 336 
responses, such as reducing sweat production. Such a role for baroreceptors (should it exist) 337 
would be advantageous for individuals whose occupational or recreational pursuits render 338 
them passively hyperthermic, dehydrated, and at an elevated risk of a hemorrhagic injury that 339 
would induce further volume loss (e.g. soldiers, firefighters, miners, etc.).  The findings of the 340 
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current study not only suggest that baroreceptor unloading during such scenarios does not 341 
preserve fluid status secondary to decreasing sweat production, but also that reloading of the 342 
baroreceptors is unlikely to improve sweat production and therefore contribute to temperature 343 
regulation.  344 
 345 
 346 
CONCLUSION 347 
The current study examined whether baroreceptor unloading limits the increase in 348 
forearm sweat rate and cutaneous vascular conductance during severe passive heat stress. 349 
The results show that reloading of cardiopulmonary baroreceptors (via rapid saline infusion) 350 
elicits large increases in cutaneous vascular conductance, consistent with prior observations 351 
(3), without any effect upon forearm sweat rate. Furthermore, infusion of phenylephrine to 352 
reload arterial baroreceptors did not elicit further increases in forearm sweat production. These 353 
findings suggest that cardiopulmonary and arterial baroreceptor unloading during severe 354 
passive heat stress do not limit increases in sweat rate.  355 
 356 
 357 
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TABLES 363 
 364 
Table 1: Thermal and hemodynamic data during normothermia, hyperthermia (pre-saline infusion), and 365 
during the last minute of rapid saline infusion (mean ± SD). 366 
 367 
 Normothermia Hyperthermia Saline Infusion 
Intestinal temperature (°C) 37.0 ± 0.3 38.9 ± 0.4 * 39.1 ± 0.5 *† 
Mean skin temperature (°C) 34.7 ± 0.2 39.3 ± 0.8 * 39.2 ± 0.8 * 
Mean body temperature (°C) 36.6 ± 0.3 39.0 ± 0.5 * 39.1 ± 0.5 *† 
MAP (mmHg) 82 ± 8 79 ± 11 74 ± 8 * 
Heart rate (bpm) 59 ± 10 113 ± 17 * 112 ± 14 * 
 368 
MAP, mean arterial pressure; * Different from normothermia (P≤0.023); † Different from hyperthermia 369 
(P=0.005). 370 
 371 
 372 
Table 2: Thermal and hemodynamic data during normothermia, hyperthermia (pre-phenylephrine 373 
infusion), and during the last minute of phenylephrine infusion (mean ± SD). 374 
 375 
 
Normothermia Hyperthermia 
Phenylephrine 
Infusion 
Intestinal temperature (°C) 36.9 ± 0.2 38.7 ± 0.4 * 38.9 ± 0.4 *† 
Mean skin temperature (°C) 33.9 ± 0.5 39.9 ± 0.5 * 39.9 ± 0.4 * 
Mean body temperature (°C) 36.3 ± 0.2 39.0 ± 0.4 * 39.1 ± 0.4 *† 
Heart rate (bpm) 56 ± 9 107 ± 16 * 95 ± 16 *† 
 376 
* Different from normothermia (P<0.001); † Different from hyperthermia (P<0.001). 377 
 378 
  379 
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FIGURES 380 
 381 
 382 
Figure 1: Central venous pressure (CVP, top, n=8), forearm sweat rate (middle, n=10), and cutaneous 383 
vascular conductance (CVC, bottom, n=10) immediately prior to passive heat stress (normothermia), 384 
during hyperthermia, and throughout the rapid saline infusion (mean ± SD). Data during the infusion are 385 
presented until the last common time point of saline infusion (4 min), while the last data point 386 
represents the mean infusion time and associated response across all subjects. *Different from 387 
normothermia (P≤0.028); †Different from hyperthermia (P≤0.051). 388 
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 389 
 390 
Figure 2: Mean arterial pressure (MAP, top) and forearm sweat rate (bottom) immediately prior to 391 
passive heat stress (normothermia), during hyperthermia, and throughout the phenylephrine infusion 392 
(mean ± SD, n=11).  *Different from normothermia (P≤0.048); †Different from hyperthermia (P≤0.007). 393 
 394 
  395 
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